FDA Brief

Warning letters Drugs

FDA warning letter to

Eagle Energy USA, Inc.

High riskIssued Dec 1, 2021Posted Dec 7, 2021Center for Drug Evaluation and Research | CDER

FDA warned Eagle Energy USA that its inhalable Caffeine Pen products are unapproved new drugs with safety concerns.

What happened

In September 2021, FDA reviewed Eagle Energy's website and Facebook page and found it took orders for Caffeine Pen products in Lychee Ice and Guarana Berry. FDA said website, social media, and packaging claims showed the products were intended as drugs, but they were marketed as dietary supplements even though intended for inhalation. FDA cited safety concerns from inhaling ingredients and said no approved drug applications were in effect.

What FDA found

  1. The Caffeine Pen products are unapproved new drugs because they are intended for drug uses and no FDA-approved application is in effect.

    sections 505(a) and 301(d), FD&C Act, 21 U.S.C. 355(a) and 331(d)
  2. The products are not dietary supplements because their labeling says they are intended for inhalation, not ingestion.

    section 201(ff)(2)(A)(i), FD&C Act, 21 U.S.C. 321(ff)(2)(A)(i)
  3. The products are drugs because labeling claims they affect body structure or function and treat or prevent conditions.

    section 201(g)(1), FD&C Act, 21 U.S.C. 321(g)(1)
  4. The products are new drugs because they are not generally recognized as safe and effective for the claimed uses.

    section 201(p), FD&C Act, 21 U.S.C. 321(p)
  5. Inhaling the products raises safety concerns, including possible laryngospasm, bronchospasm, tissue toxicity, or systemic effects.

What FDA wants

FDA asks Eagle Energy to notify it in writing within 15 working days of steps taken to address the violations and prevent recurrence, with related documentation. If the company believes it is not violating the law, it must include reasoning and supporting information.

Who should pay attention

  • companies selling inhalable caffeine or energy products
  • retailers and distributors of unapproved drug products
  • supplement brands considering inhalation delivery

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk